HIDRADENITIS
Clinical trials for HIDRADENITIS explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS trials appear
Sign up with your email to follow new studies for HIDRADENITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for painful skin condition: drug trial targets HS Flare-Ups
Disease control TerminatedThis study tested a drug called amlitelimab in 90 adults aged 18-70 with moderate to severe hidradenitis suppurativa (HS), a painful skin condition causing boils and tunnels. The goal was to see if the drug reduces skin abscesses and inflammation better than a placebo over 16 wee…
Matched conditions: HIDRADENITIS
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 17, 2026 07:58 UTC
-
Oral drug tested for tough skin conditions halted early
Disease control TerminatedThis study tested an oral medication called INF904 in adults with moderate to severe chronic hives or hidradenitis suppurativa (a painful skin condition). The main goal was to check the drug's safety and how it moves through the body over a 28-day treatment period. The trial was …
Matched conditions: HIDRADENITIS
Phase: PHASE2 • Sponsor: InflaRx GmbH • Aim: Disease control
Last updated Apr 13, 2026 20:23 UTC